Literature DB >> 24948106

Effect of ozonide OZ418 against Schistosoma japonicum harbored in mice.

Jian Xue1, Xiaofang Wang, Yuxiang Dong, Jonathan L Vennerstrom, Shu-hua Xiao.   

Abstract

The in vitro and in vivo efficacies of ozonide carboxylic acid OZ418 against Schistosoma japonicum were investigated. For in vitro experiments, juvenile (14-day-old) and adult schistosomes were collected from mice infected with 80-100 S. japonicum cercariae for 14 and 35 days post-infection and the worms were maintained in Roswell Park Memorial Institute (RPMI) 1640 supplemented by 10% calf serum. Against 35-day-old adult S. japonicum, OZ418 resulted in weakened worm motor activity, injury to the worm body, emergence of vacuoles along the worm surface, and death. A similar outcome was seen in 14-day-old juvenile S. japonicum exposed to OZ418. Ineffective concentrations (1, 5, and 10 μg/mL) of OZ418 also interacted with hemin to significantly increase the killing effect against adult schistosomes. The LC50 value of OZ418 against juvenile (14-day-old) and adult schistosomes were identical--16.2 μg/mL, whereas the corresponding LC95 values were 30.7 and 22.7 μg/mL, respectively. Treatment of adult and juvenile (14-day-old) S. japonicum-infected mice with single 200-400-mg/kg oral doses of OZ418 produced total worm burden reductions of 68.5-84.1 and 37.5-50.9%, respectively. Further study showed that in mice infected with various stages of schistosomes and treated with a single oral OZ418 400 mg/kg, poor efficacy was seen in the 3-h-old juvenile worm group, while 14-day-old and 21-day-old juvenile worm groups exhibited less efficacy with total worm burden reductions of 42.6-52.4%. On the other hand, similar and higher total worm burden reductions (64.2-76.0%) were seen in the 7-day-old juvenile worm group and 28-day-old as well as 35-day-old adult worm groups. Furthermore, the mean worm burden reductions of the 7-day-old juvenile worm group and 35-day-old adult worm group were statistically significantly higher than that of the 14-day-old or 21-day-old juvenile worm group (P < 0.01 or <0.05). These data suggest that OZ418 has promising efficacy against 7-day-old juvenile and adult S. japonicum.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24948106     DOI: 10.1007/s00436-014-3988-4

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  37 in total

1.  Preventive effect of artemether in experimental animals infected with Schistosoma mansoni.

Authors:  X Shuhua; J Chollet; N A Weiss; R N Bergquist; M Tanner
Journal:  Parasitol Int       Date:  2000-03       Impact factor: 2.230

Review 2.  Drugs for the control of parasitic diseases: current status and development in schistosomiasis.

Authors:  Alan Fenwick; Lorenzo Savioli; Dirk Engels; N Robert Bergquist; Matthew H Todd
Journal:  Trends Parasitol       Date:  2003-11

3.  Miltefosine, a promising novel agent for schistosomiasis mansoni.

Authors:  Maha M Eissa; Mervat Z El-Azzouni; Eglal I Amer; Nahed M Baddour
Journal:  Int J Parasitol       Date:  2010-11-03       Impact factor: 3.981

4.  Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel.

Authors:  S H Xiao; W J Yue; Y Q Yang; J Q You
Journal:  Chin Med J (Engl)       Date:  1987-09       Impact factor: 2.628

Review 5.  Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal.

Authors:  Anthony Danso-Appiah; Sake J De Vlas
Journal:  Trends Parasitol       Date:  2002-03

6.  In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni.

Authors:  S H Xiao; B A Catto
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

7.  Identification of an antimalarial synthetic trioxolane drug development candidate.

Authors:  Jonathan L Vennerstrom; Sarah Arbe-Barnes; Reto Brun; Susan A Charman; Francis C K Chiu; Jacques Chollet; Yuxiang Dong; Arnulf Dorn; Daniel Hunziker; Hugues Matile; Kylie McIntosh; Maniyan Padmanilayam; Josefina Santo Tomas; Christian Scheurer; Bernard Scorneaux; Yuanqing Tang; Heinrich Urwyler; Sergio Wittlin; William N Charman
Journal:  Nature       Date:  2004-08-19       Impact factor: 49.962

8.  Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice.

Authors:  Luc Van Nassauw; Stephen Toovey; Joeri Van Op den Bosch; Jean-Pierre Timmermans; Jozef Vercruysse
Journal:  Travel Med Infect Dis       Date:  2008-08-08       Impact factor: 6.211

9.  Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice.

Authors:  Sanaa Botros; Samia William; Olfat Hammam; Zdenĕk Zídek; Antonín Holý
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

10.  Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire.

Authors:  Giovanna Raso; Eliézer K N'Goran; Abale Toty; Anne Luginbühl; Cynthia A Adjoua; Norbert T Tian-Bi; Isaac I Bogoch; Penelope Vounatsou; Marcel Tanner; Jürg Utzinger
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-01       Impact factor: 2.184

View more
  6 in total

1.  Structure-Activity Relationship of Antischistosomal Ozonide Carboxylic Acids.

Authors:  Jianbo Wu; Xiaofang Wang; Francis C K Chiu; Cécile Häberli; David M Shackleford; Eileen Ryan; Sriraghavan Kamaraj; Vivek J Bulbule; Alexander I Wallick; Yuxiang Dong; Karen L White; Paul H Davis; Susan A Charman; Jennifer Keiser; Jonathan L Vennerstrom
Journal:  J Med Chem       Date:  2020-03-19       Impact factor: 7.446

2.  Pharmacokinetics of the Antischistosomal Lead Ozonide OZ418 in Uninfected Mice Determined by Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Anna Leonidova; Mireille Vargas; Jörg Huwyler; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

3.  Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides.

Authors:  Yiping Wang; Rupkatha Mukhopadhyay; Sujayita Roy; Arun Kapoor; Yu-Pin Su; Susan A Charman; Gong Chen; Jianbo Wu; Xiaofang Wang; Jonathan L Vennerstrom; Ravit Arav-Boger
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 4.  Repurposing drugs for the treatment and control of helminth infections.

Authors:  Gordana Panic; Urs Duthaler; Benjamin Speich; Jennifer Keiser
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-07-30       Impact factor: 4.077

Review 5.  Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies.

Authors:  Shu-Hua Xiao; Jun Sun; Ming-Gang Chen
Journal:  Infect Dis Poverty       Date:  2018-02-07       Impact factor: 4.520

6.  Inhibition of Human Coronaviruses by Antimalarial Peroxides.

Authors:  Ayan Kumar Ghosh; Halli Miller; Konstance Knox; Madhuchhanda Kundu; Kelly J Henrickson; Ravit Arav-Boger
Journal:  ACS Infect Dis       Date:  2021-03-30       Impact factor: 5.084

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.